DK0616813T3 - Polymer antitumorsammensætning med mitoxantron - Google Patents
Polymer antitumorsammensætning med mitoxantronInfo
- Publication number
- DK0616813T3 DK0616813T3 DK94102401T DK94102401T DK0616813T3 DK 0616813 T3 DK0616813 T3 DK 0616813T3 DK 94102401 T DK94102401 T DK 94102401T DK 94102401 T DK94102401 T DK 94102401T DK 0616813 T3 DK0616813 T3 DK 0616813T3
- Authority
- DK
- Denmark
- Prior art keywords
- mitoxantrone
- polymer
- antitumor composition
- antitumor
- mve
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/037,149 US5378456A (en) | 1993-03-25 | 1993-03-25 | Antitumor mitoxantrone polymeric compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0616813T3 true DK0616813T3 (da) | 2002-04-15 |
Family
ID=21892713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94102401T DK0616813T3 (da) | 1993-03-25 | 1994-02-17 | Polymer antitumorsammensætning med mitoxantron |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5378456A (de) |
| EP (1) | EP0616813B1 (de) |
| JP (1) | JPH06321927A (de) |
| KR (1) | KR100348380B1 (de) |
| AT (1) | ATE210996T1 (de) |
| CA (1) | CA2119675A1 (de) |
| DE (1) | DE69429468T2 (de) |
| DK (1) | DK0616813T3 (de) |
| ES (1) | ES2169049T3 (de) |
| PT (1) | PT616813E (de) |
| SG (1) | SG52340A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0706376B2 (de) | 1993-07-19 | 2007-08-08 | Angiotech Pharmaceuticals, Inc. | Anti-angiogene mittel und verfahren zu deren verwendung |
| US20030203976A1 (en) | 1993-07-19 | 2003-10-30 | William L. Hunter | Anti-angiogenic compositions and methods of use |
| US5609867A (en) | 1994-11-01 | 1997-03-11 | American Cyanamid Company | Polymeric antitumor agents |
| US6624317B1 (en) | 2000-09-25 | 2003-09-23 | The University Of North Carolina At Chapel Hill | Taxoid conjugates as antimitotic and antitumor agents |
| MXPA03003401A (es) * | 2000-10-16 | 2004-06-30 | Neopharm Inc | Formulacion liposomica de mitoxantrona. |
| GB0123232D0 (en) * | 2001-09-26 | 2001-11-21 | Smith & Nephew | Polymers |
| JP2010520852A (ja) * | 2006-10-27 | 2010-06-17 | ジュセッペ・トリジャンテ | 除毛（脱毛）のための化合物と方法 |
| AU2014293011A1 (en) * | 2013-07-26 | 2016-03-17 | Race Oncology Ltd. | Compositions to improve the therapeutic benefit of bisantrene |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4182800A (en) * | 1977-07-16 | 1980-01-08 | Hercules Incorporated | Methotrexate-divinyl ether--maleic anhydride copolymer reaction product |
| JPS6067490A (ja) * | 1983-09-24 | 1985-04-17 | Agency Of Ind Science & Technol | アントラサイクリン系抗生物質誘導体及びその製造方法 |
| JPS6067426A (ja) * | 1983-09-24 | 1985-04-17 | Agency Of Ind Science & Technol | 低毒性制ガン剤 |
| US4520162A (en) * | 1983-09-24 | 1985-05-28 | Director-General Of The Agency Of Industrial Science & Technology | Polymeric compounds with sustained anti-tumor activity and a method for the preparation thereof |
| GB8413464D0 (en) * | 1984-05-25 | 1984-07-04 | Erba Farmitalia | Anthracycline-anionic polymer conjugates |
| CA1306693C (en) * | 1986-10-07 | 1992-08-25 | Sergio Tognella | Pharmaceutical compositions having antineoplastic activity |
| PT93772A (pt) * | 1989-04-17 | 1991-01-08 | Searle & Co | Processo para a preparacao de composicoes para o tratamento de neoplasias, contendo um agente anti-neoplastico, por exemplo doxorubicina e um agente protector para reduzir os efeitos secundarios, por exemplo carbetimer |
| JPH0762049B2 (ja) * | 1991-03-18 | 1995-07-05 | 工業技術院長 | 高分子マイトマイシンｃ誘導体及びその製造方法 |
| JP3069646B2 (ja) * | 1991-05-28 | 2000-07-24 | 三共株式会社 | ５−フルオロウリジン−高分子複合体 |
-
1993
- 1993-03-25 US US08/037,149 patent/US5378456A/en not_active Expired - Lifetime
-
1994
- 1994-02-17 AT AT94102401T patent/ATE210996T1/de not_active IP Right Cessation
- 1994-02-17 ES ES94102401T patent/ES2169049T3/es not_active Expired - Lifetime
- 1994-02-17 EP EP94102401A patent/EP0616813B1/de not_active Expired - Lifetime
- 1994-02-17 DK DK94102401T patent/DK0616813T3/da active
- 1994-02-17 SG SG1996003102A patent/SG52340A1/en unknown
- 1994-02-17 PT PT94102401T patent/PT616813E/pt unknown
- 1994-02-17 DE DE69429468T patent/DE69429468T2/de not_active Expired - Lifetime
- 1994-03-22 JP JP6073757A patent/JPH06321927A/ja active Pending
- 1994-03-23 CA CA002119675A patent/CA2119675A1/en not_active Abandoned
- 1994-03-24 KR KR1019940005977A patent/KR100348380B1/ko not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69429468D1 (de) | 2002-01-31 |
| EP0616813B1 (de) | 2001-12-19 |
| KR940021068A (ko) | 1994-10-17 |
| EP0616813A2 (de) | 1994-09-28 |
| ES2169049T3 (es) | 2002-07-01 |
| SG52340A1 (en) | 1998-09-28 |
| EP0616813A3 (de) | 1995-03-29 |
| JPH06321927A (ja) | 1994-11-22 |
| PT616813E (pt) | 2002-06-28 |
| US5378456A (en) | 1995-01-03 |
| DE69429468T2 (de) | 2002-08-14 |
| CA2119675A1 (en) | 1994-09-26 |
| ATE210996T1 (de) | 2002-01-15 |
| KR100348380B1 (ko) | 2004-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20002547L (no) | Poly(vinylamin)-baserte superabsorberende geler og fremgangsmÕte for fremstilling derav | |
| ES2131266T3 (es) | Copolimeros de bloques lineales, procedimiento para su preparacion y composiciones adhesivas que los contienen. | |
| BR9911754A (pt) | Copolìmero linear de ciclodextrina, composição terapêutica, composição de ciclodextrina, processos de preparo de um copolìmero linear de ciclodextrina, e de um copolìmero linear de ciclodextrina oxidada, processo para produzir um polìmero reticulado de ciclodextrina, e, processo de tratamento | |
| DK1133989T3 (da) | Polymersammensætning til anvendelse i terapi | |
| EP0848960A3 (de) | Haft- und Bindemittel für dermale oder transdermale Therapiesysteme | |
| AU4646397A (en) | Polymeric membranes and polymer articles having hydrophilic surface and method for their preparation | |
| DK0616813T3 (da) | Polymer antitumorsammensætning med mitoxantron | |
| ES8800605A1 (es) | Procedimiento para preparar una composicion coloeada de utilidad en cirugia ocular. | |
| AU628095B2 (en) | Chelants possessing ortho ligating functionality and complexes thereof | |
| ES8705012A1 (es) | Un procedimiento para preparar una composicion para marcar carreteras | |
| ES451166A1 (es) | Procedimiento para preparar liquidos acuosos de alimentacionpara el tratamiento de agua. | |
| AU583624B2 (en) | Polymers with pendant isocyanatocarbonyl groups, and their production processes, and compositions comprising them | |
| GR3006310T3 (de) | ||
| FR2707638B1 (fr) | Nouveaux dérivés d'amino-acides, leurs procédés de préparation et leur application thérapeutique. | |
| BR9101442A (pt) | Composicao de polimero de policetona | |
| MX169883B (es) | Mezclas polimericas de policarbonato, terpolimero de estireno y resina abs | |
| NO996212L (no) | Polymerblanding med høy transparens | |
| EP0544802A4 (en) | Methods and compositions for treating t-cell mediated diseases | |
| JPS56141338A (en) | Crosslinked polyolefin composition | |
| EP0237284A3 (de) | Polyester-Zusammensetzung mit verbesserter Fliessfähigkeit | |
| AU543542B2 (en) | Polymer compositions for treating tumours | |
| GB2254333A (en) | Crosslinkable polymers | |
| CA1271281A (en) | Biocompatible material for treatment of tissular or organic defects | |
| FI973499A0 (fi) | Kasvaintenvastaisia bentsotiopyranoindatsoleja | |
| AU5766790A (en) | Liquid polymer composition, and method of use |